Sarah A. Morrow, MD, FRCPC, MS

morrow Associate Professor of Neurology, Western University
Office: London Health Sciences Centre, University Hospital B10-133
Phone: 519-663-2993
Secretary: Ashley MacLean

 

 

Bio Sketch

Dr. Morrow received her MD from the University of Calgary and completed her residency training in neurology at Western University. This was followed by a clinical fellowship in MS at the London MS clinic at Western University and a research fellowship on Cognition and MS with Dr. Ralph Benedict, a neuropsychologist, at the Jacobs Neurologic Institute in Buffalo NY. Dr. Morrow has also completed a Master's of Science in Epidemiology at the State University of New York at Buffalo. She joined the Department in 2010.

In addition to her clinical work in the London MS clinic, she established the first Multiple Sclerosis Cognitive clinic in Canada located at Parkwood Institute. She currently has over 60 peer-reviewed publications in the area of MS. She is a Board member for the Consortium of MS Centers and on the editorial board of both the International Journal of MS care and the Canadian Journal of Neurological Sciences. She has been invited to present her research at numerous national and international conferences and is on the steering committee of MS in the 21st Century, an international collaboration with the aim of defining how MS treatment and standard of care should look in the 21st century.


 

Research

Cognitive Dysfunction in MS, Corticosteroid Treatment for MS


Medical Interests

Multiple Sclerosis and related diseases


Honours and Awards

  • 2010, Young Investigaros Award, ECTRIMS

Publications

PubMed Publications Listing

Publications

Welk B, McArthur E, Ordon M, Morrow SA, Hayward J, Dixon S. The risk of dementia with the use of 5 alpha reductase inhibitors.J Neurol Sci. 2017 Aug 15;379:109-111. doi: 10.1016/j.jns.2017.05.064. Epub 2017 May 31. PubMed PMID: 28716218.

Berger W, Payne MWC, Morrow SA. Self-reported maximum walking distance in persons with MS may affect the EDSS. J Neurol Sci. 2017 Aug 15;379:77-80. doi: 10.1016/j.jns.2017.05.035. Epub 2017 May 17. PubMed PMID: 28716284

Classen S, Krasniuk S, Morrow SA, Alvarez L, Monahan M, Danter T, Rosehart H. Visual Correlates of Fitness to Drive in Adults With Multiple Sclerosis. OTJR (Thorofare N J). 2017 Aug 1:1539449217718841. doi: 10.1177/1539449217718841. [Epub ahead of print] PubMed PMID: 28766462.

Morrow SA, Classen S, Monahan M, Danter T, Taylor R, Krasniuk S, Rosehart H, He W. On-road assessment of fitness-to-drive in persons with MS with cognitive impairment: A prospective study. Mult Scler. 2017 Aug 1:1352458517723991. doi: 10.1177/1352458517723991. [Epub ahead of print] PubMed PMID: 28782411.

Fakolade A, Lamarre J, Latimer-Cheung A, Parsons T, Morrow SA, Finlayson M. Understanding leisure-time physical activity: Voices of people with MS who have moderate-to-severe disability and their family caregivers. Health Expect. 2017 Jul 19. doi: 10.1111/hex.12600. [Epub ahead of print] PubMed PMID: 28722772

Walker LAS, Marino D, Berard JA, Feinstein A, Morrow SA, Cousineau D. Canadian Normative Data for Minimal Assessment of Cognitive Function in Multiple Sclerosis. Can J Neurol Sci. 2017 Jul 7:1-9. doi: 10.1017/cjn.2017.199. [Epub ahead of print] PubMed PMID: 28683843.

Krasniuk S, Classen S, Morrow SA, Monahan M, Danter T, Rosehart H, He W. Driving Errors That Predict On-Road Outcomes in Adults With Multiple Sclerosis. OTJR (Thorofare N J). 2017 May 1:1539449217708554. doi: 10.1177/1539449217708554. [Epub ahead of print] PMID: 28539098

Morrow SA, Menon S, Rosehart H, Sharma M. Developing easy to perform routine MRI measurements as potential surrogates for cognitive impairment in MS. Clin Neurol Neurosurg. 2017 Feb;153:73-78. doi: 10.1016/j.clineuro.2016.12.015. Epub 2016 Dec 29. PMID: 28061362

Hanna J, Santo JB, Blair M, Smolewska K, Warriner E, Morrow SA. Comparing depression screening tools in persons with multiple sclerosis (MS). Rehabil Psychol. 2017 Feb;62(1):20-24. doi: 10.1037/rep0000115. Epub 2016 Dec 5. PMID: 27918176

Morrow SA, Rosehart H, Johnson AM. The effect of Fampridine-SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS. Mult Scler Relat Disord. 2017 Jan;11:4-9. doi: 10.1016/j.msard.2016.10.011. Epub 2016 Nov 4. PMID: 28104253

Classen S, Krasniuk S, Alvarez L, Monahan M, Morrow SA, Danter T. Development and Validity of Western University's On-Road Assessment. OTJR (Thorofare N J). 2017 Jan;37(1):14-29. doi: 10.1177/1539449216672859. Epub 2016 Oct 15. PMID: 27744272

News


Social Media Coverage